NCT05946668View on ClinicalTrials.gov

Evaluation of Vaginal Microbiome as a Biomarker for the Improvement of Vaginal Health in Women With Breast Cancer, ARISE Study

CompletedOBSERVATIONAL
Enrollment

35

Participants

Timeline

Start Date

June 6, 2023

Primary Completion Date

March 1, 2025

Study Completion Date

March 1, 2025

Conditions
Breast Neoplasms
Interventions
PROCEDURE

Biospecimen Collection

Undergo vaginal specimen self-collection via vaginal swab collection kit

OTHER

Electronic Health Record Review

Medical records reviewed

OTHER

Questionnaire Administration

Complete questionnaires

Trial Locations (1)

43210

Ohio State University Comprehensive Cancer Center, Columbus

All Listed Sponsors
lead

Ohio State University Comprehensive Cancer Center

OTHER

NCT05946668 - Evaluation of Vaginal Microbiome as a Biomarker for the Improvement of Vaginal Health in Women With Breast Cancer, ARISE Study | Biotech Hunter | Biotech Hunter